Company Info
| Phone: | (858) 617-7600 |
| Year Established: | 1992 |
| Ticker: | NBIX |
| Exchange: | NASDAQ |
Contacts
| Primary: | Kevin C. Gorman, Ph.D. CEO |
| Other: | Matt Abernethy CFO Eric Benevich CCO David W. Boyer Chief Corporate Affairs Officer Kyle W. Gano, Ph.D CBO Dimitri E. Grigoriadis, Ph.D. Chief Research Officer Ingrid Delaet, Ph.D. Chief Regulatory Officer Darin Lippoldt Chief Legal Officer Eiry W. Roberts, M.D. CMO Jude Onyia, Ph.D. CSO |
Company Description
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.
